| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | IN BRIEF: Nuformix interim loss narrows; aims to raise value of assets | 1 | Alliance News | ||
| Do | Nuformix PLC - Half Year Report | - | RNS | ||
| 31.03. | Nuformix PLC - Total Voting Rights | - | RNS | ||
| 11.03. | SMALL-CAP WINNERS & LOSERS: Nuformix down after GBP1.0 million placing | 2 | Alliance News | ||
| 11.03. | Nuformix PLC - £1.0 million Placing | - | RNS | ||
| 10.03. | Nuformix erhält FDA-Orphan-Drug-Status für Behandlung von Lungenfibrose | 1 | Investing.com Deutsch | ||
| NUFORMIX Aktie jetzt für 0€ handeln | |||||
| 10.03. | Nuformix receives FDA orphan drug status for IPF treatment | 1 | Investing.com | ||
| 10.03. | Nuformix PLC - Confirmation of US ODD for NXP002 in IPF | - | RNS | ||
| 03.03. | Nuformix PLC - Result of AGM | - | RNS | ||
| 05.02. | Nuformix PLC - Posting of Annual Report and Notice of AGM | - | RNS | ||
| 27.01. | Nuformix focused on lead asset for pulmonary fibrosis as loss narrows | 1 | Alliance News | ||
| 27.01. | Nuformix PLC - Annual Results for period ended 30 September 2025 | 1 | RNS | ||
| 29.10.25 | XFRA CAPITAL ADJUSTMENT INFORMATION - 29.10.2025 | 1.199 | Xetra Newsboard | Das Instrument 1TY NL0013654783 PROSUS NV EO -,05 EQUITY wird cum Kapitalmassnahme gehandelt am 29.10.2025 und ex Kapitalmassnahme am 30.10.2025 The instrument 1TY NL0013654783 PROSUS NV EO -,05 EQUITY... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONANO GENOMICS | 1,250 | 0,00 % | Bionano Genomics: Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures | ||
| TONIX PHARMACEUTICALS | 10,745 | +1,66 % | Tonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 ... | Real-world analysis of three years of closed claims data from Symphony Health focused on the third year of the study (2023-2024), comprised of more than 261,000 U.S. adults with fibromyalgia Data... ► Artikel lesen | |
| CHRISTINA LAKE CANNABIS | 0,010 | -28,57 % | Christina Lake Cannabis Corp: Christina Lake investor Milia acquires 5.03M shares | ||
| PSYCHED WELLNESS | 0,005 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness Highlights U.S. Federal Policy Momentum Supporting Psychedelic Sector | Toronto, Ontario--(Newsfile Corp. - April 23, 2026) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company"), a life sciences company focused on the production and distribution... ► Artikel lesen | |
| JAGUAR HEALTH | 3,220 | -1,53 % | Jaguar Health, Inc.: Jaguar Health Research in Ethnobotanical Medicine Helps Advance Crofelemer Development for Genetically Defined Rare Congenital Gastrointestinal Disorders | Crofelemer delayed-release tablets are Jaguar's FDA-approved prescription drug under botanical guidance ("botanical drug") derived from the Croton lechleri tree. Crofelemer, in a novel liquid formulation... ► Artikel lesen | |
| GREENRISE GLOBAL BRANDS | 0,005 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| NUMINUS WELLNESS | 0,027 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.04.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 23.04.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.04.2026ISIN NameAU000000BMG3 BMG... ► Artikel lesen | |
| BETTERLIFE PHARMA | 0,030 | 0,00 % | BetterLife Pharma Inc. - 20-F, Annual and transition report of foreign private issuers | ||
| MEDIPHARM LABS | 0,050 | +3,09 % | Medipharm Labs Corp: Medipharm Labs reminds holders of June 17 AGSM | ||
| PROMINO NUTRITIONAL SCIENCES | 0,018 | +12,50 % | Promino Nutritional Sciences, Inc.: Promino Delivered to Stanley Cup Final Locker Room as Ambassador Jack Eichel Competes for Championship | Burlington, Ontario--(Newsfile Corp. - June 2, 2026) - Promino Nutritional Sciences, Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) ("Promino" or the "Company"), a leader in muscle health and performance... ► Artikel lesen | |
| ADDEX THERAPEUTICS | 0,046 | 0,00 % | Addex Therapeutics: Addex Reports Full Year 2025 Financial Results and Provides Corporate Update | GABAB PAM chronic cough candidate continued towards clinic after demonstrating robust anti-tussive activity in multiple disease modelsContinued to reposition dipraglurant mGlu5 NAM for brain injury... ► Artikel lesen | |
| ARGENT BIOPHARMA | 0,015 | -9,09 % | ARGENT BIOPHARMA LIMITED: Long Term Aquiol Licensing and Supply Agreement | ||
| CANNABIST COMPANY | 0,020 | 0,00 % | XFRA VW5: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCANNABIST CO.HLDG.INC... ► Artikel lesen | |
| IANTHUS CAPITAL | 0,001 | 0,00 % | iAnthus Capital Holdings, Inc.: iAnthus Reports Fiscal First Quarter 2026 Financial Results | NEW YORK and TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN, OTCID: ITHUF), which owns, operates, and partners with regulated cannabis... ► Artikel lesen | |
| CENTR BRANDS | 0,001 | 0,00 % | Centr Brands Corp (2): Centr Brands arranges $100,000 debenture offering |